Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Patient-centric, Observational, Consecutive Enrollment, Non-interventional Study of Patients At Risk for Fracture Non-union Treated With EXOGEN Compared to a National Healthcare Claims Database Control

NCT03382483 is registered in ClinicalTrials.gov with Bioventus LLC as lead sponsor.

NCT NCT03382483
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03382483 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Patient-centric, Observational, Consecutive Enrollment, Non-interventional Study of Patients At Risk for Fracture Non-union Treated With EXOGEN Compared to a National Healthcare Claims Database Control
Lead sponsor
Bioventus LLC
Phase
Observational
Overall status
Completed
Start date
October 16, 2017
Completion date
May 1, 2022
Enrollment
12,387 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mitigation of fracture non-union in patients at risk